Faron Pharmaceuticals Oy (LON:FARN) Stock Crosses Below Fifty Day Moving Average – What’s Next?
by Renee Jackson · The Cerbat GemFaron Pharmaceuticals Oy (LON:FARN – Get Free Report) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 44.03 and traded as low as GBX 40. Faron Pharmaceuticals Oy shares last traded at GBX 42.50, with a volume of 27,256 shares trading hands.
Faron Pharmaceuticals Oy Price Performance
The firm has a market cap of £84.79 million, a price-to-earnings ratio of -1.93 and a beta of 1.11. The company has a debt-to-equity ratio of -133.35, a quick ratio of 1.09 and a current ratio of 0.84. The business has a 50 day simple moving average of GBX 44.03 and a 200-day simple moving average of GBX 113.37.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.